000144896 001__ 144896
000144896 005__ 20240424120356.0
000144896 0247_ $$2doi$$a10.1002/mgg3.87
000144896 0247_ $$2pmid$$apmid:25333062
000144896 0247_ $$2pmc$$apmc:PMC4190872
000144896 0247_ $$2altmetric$$aaltmetric:2801824
000144896 037__ $$aDZNE-2020-00305
000144896 041__ $$aEnglish
000144896 082__ $$a610
000144896 1001_ $$aSchlipf, Nina A$$b0
000144896 245__ $$aAP5Z1/SPG48 frequency in autosomal recessive and sporadic spastic paraplegia.
000144896 260__ $$aChichester [u.a.]$$bWiley$$c2014
000144896 264_1 $$2Crossref$$3online$$bWiley$$c2014-05-25
000144896 264_1 $$2Crossref$$3print$$bWiley$$c2014-09-01
000144896 3367_ $$2DRIVER$$aarticle
000144896 3367_ $$2DataCite$$aOutput Types/Journal article
000144896 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1713949957_26792
000144896 3367_ $$2BibTeX$$aARTICLE
000144896 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144896 3367_ $$00$$2EndNote$$aJournal Article
000144896 520__ $$aHereditary spastic paraplegias (HSP) constitute a rare and highly heterogeneous group of neurodegenerative disorders, defined clinically by progressive lower limb spasticity and pyramidal weakness. Autosomal recessive HSP as well as sporadic cases present a significant diagnostic challenge. Mutations in AP5Z1, a gene playing a role in intracellular membrane trafficking, have been recently reported to be associated with spastic paraplegia type 48 (SPG48). Our objective was to determine the relative frequency and clinical relevance of AP5Z1 mutations in a large cohort of 127 HSP patients. We applied a targeted next-generation sequencing approach to analyze all coding exons of the AP5Z1 gene. With the output of high-quality reads and a mean coverage of 51-fold, we demonstrated a robust detection of variants. One 43-year-old female with sporadic complicated paraplegia showed two heterozygous nonsynonymous variants of unknown significance (VUS3; p.[R292W];[(T756I)]). Thus, AP5Z1 gene mutations are rare, at least in Europeans. Due to its low frequency, systematic genetic testing for AP5Z1 mutations is not recommended until larger studies are performed to add further evidence. Our findings demonstrate that amplicon-based deep sequencing is technically feasible and allows a compact molecular characterization of multiple HSP patients with high accuracy.
000144896 536__ $$0G:(DE-HGF)POF3-345$$a345 - Population Studies and Genetics (POF3-345)$$cPOF3-345$$fPOF III$$x0
000144896 542__ $$2Crossref$$i2014-05-25$$uhttp://doi.wiley.com/10.1002/tdm_license_1.1
000144896 542__ $$2Crossref$$i2014-05-25$$uhttp://creativecommons.org/licenses/by/3.0/
000144896 588__ $$aDataset connected to CrossRef, PubMed,
000144896 7001_ $$0P:(DE-HGF)0$$aSchüle, Rebecca$$b1
000144896 7001_ $$aKlimpe, Sven$$b2
000144896 7001_ $$0P:(DE-2719)9000150$$aKarle, Kathrin N$$b3$$udzne
000144896 7001_ $$0P:(DE-2719)2811275$$aSynofzik, Matthis$$b4$$udzne
000144896 7001_ $$0P:(DE-2719)9000352$$aWolf, Julia$$b5$$udzne
000144896 7001_ $$aRiess, Olaf$$b6
000144896 7001_ $$0P:(DE-2719)2810795$$aSchöls, Ludger$$b7$$udzne
000144896 7001_ $$0P:(DE-HGF)0$$aBauer, Peter$$b8$$eCorresponding author
000144896 77318 $$2Crossref$$3journal-article$$a10.1002/mgg3.87$$b : Wiley, 2014-05-25$$n5$$p379-382$$tMolecular Genetics & Genomic Medicine$$v2$$x2324-9269$$y2014
000144896 773__ $$0PERI:(DE-600)2734884-2$$a10.1002/mgg3.87$$gVol. 2, no. 5, p. 379 - 382$$n5$$p379-382$$tMolecular genetics & genomic medicine$$v2$$x2324-9269$$y2014
000144896 8564_ $$uhttps://pub.dzne.de/record/144896/files/DZNE-2020-00305.pdf$$yOpenAccess
000144896 8564_ $$uhttps://pub.dzne.de/record/144896/files/DZNE-2020-00305.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000144896 909CO $$ooai:pub.dzne.de:144896$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000144896 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000150$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000144896 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811275$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000144896 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000352$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000144896 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810795$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000144896 9131_ $$0G:(DE-HGF)POF3-345$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vPopulation Studies and Genetics$$x0
000144896 9141_ $$y2014
000144896 915__ $$0LIC:(DE-HGF)CCBY3$$2HGFVOC$$aCreative Commons Attribution CC BY 3.0
000144896 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL GENET GENOM MED : 2018$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000144896 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$f2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-01-05
000144896 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-05
000144896 9201_ $$0I:(DE-2719)5000057$$kExt HIH$$lExt Hertie-Institut für klinische Hirnforschung$$x0
000144896 9201_ $$0I:(DE-2719)1210000$$kAG Gasser$$lParkinson Genetics$$x1
000144896 9201_ $$0I:(DE-2719)5000058$$kExt UKT$$lExt Universitätsklinikum Tübingen$$x2
000144896 9201_ $$0I:(DE-2719)5000005$$kAG Schöls$$lClinical Neurogenetics$$x3
000144896 980__ $$ajournal
000144896 980__ $$aVDB
000144896 980__ $$aUNRESTRICTED
000144896 980__ $$aI:(DE-2719)5000057
000144896 980__ $$aI:(DE-2719)1210000
000144896 980__ $$aI:(DE-2719)5000058
000144896 980__ $$aI:(DE-2719)5000005
000144896 9801_ $$aFullTexts
000144896 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1007/s00401-013-1115-8$$o10.1007/s00401-013-1115-8
000144896 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1371/journal.pbio.1001170$$o10.1371/journal.pbio.1001170
000144896 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1126/science.1247363$$o10.1126/science.1247363
000144896 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1371/journal.pbio.1000408$$o10.1371/journal.pbio.1000408
000144896 999C5 $$2Crossref$$9-- missing cx lookup --$$a10.1038/ng1980$$o10.1038/ng1980